Literature DB >> 7729329

The diagnosis and management of uveitis.

E Anglade1, S M Whitcup.   

Abstract

The diagnosis and management of uveitis is complicated and challenging. The protean signs and symptoms seen in patients with uveitis may lead to a diagnostic dilemma. A carefully taken history with particular attention to demographic factors and meticulous physical examination are crucial to guiding diagnostic testing. Tailoring the diagnostic approach in patients with uveitis frequently yields useful data in contrast to blanketing every possible uveitic entity. It is also important to distinguish among various aetiologies, including infectious and neoplastic causes which may respond to specific therapy. Medical treatment of noninfectious uveitis must have clear objectives including reduction of inflammation, relief of symptoms and restoration of visual functioning. Familiarity with possible symptoms and signs of adverse drug reactions is essential early in the course of treatment so that their effects may be minimised. Appropriate therapy of presumed autoimmune uveitis is based on disease severity, presence or absence of bilateral disease and the health status of the patient.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7729329     DOI: 10.2165/00003495-199549020-00006

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  59 in total

Review 1.  FK 506: historical perspectives.

Authors:  T Goto; T Kino; H Hatanaka; M Okuhara; M Kohsaka; H Aoki; H Imanaka
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

2.  Granulomas in sympathetic ophthalmia and sarcoidosis. Immunohistochemical study.

Authors:  C C Chan; D BenEzra; S M Hsu; A G Palestine; R B Nussenblatt
Journal:  Arch Ophthalmol       Date:  1985-02

3.  Treatment of uveitis with methotrexate.

Authors:  M Lazar; M J Weiner; I H Leopold
Journal:  Am J Ophthalmol       Date:  1969-03       Impact factor: 5.258

4.  The use of chlorambucil in intractable idiopathic uveitis.

Authors:  W A Godfrey; W V Epstein; G R O'Connor; S J Kimura; M J Hogan; R A Nozik
Journal:  Am J Ophthalmol       Date:  1974-09       Impact factor: 5.258

5.  Effect of folate compounds on the accumulation of methotrexate and the activity of dihydrofolate reductase in liver, kidney and small intestine of the mouse.

Authors:  S P Rothenberg; M P Iqbal; M da Costa
Journal:  J Pharmacol Exp Ther       Date:  1982-12       Impact factor: 4.030

6.  Combination low dose cyclosporin A and steroid therapy in chronic intraocular inflammation.

Authors:  H M Towler; P H Whiting; J V Forrester
Journal:  Eye (Lond)       Date:  1990       Impact factor: 3.775

7.  Chlorambucil in the treatment of uveitis and meningoencephalitis of Behçet's disease.

Authors:  J D O'Duffy; D M Robertson; N P Goldstein
Journal:  Am J Med       Date:  1984-01       Impact factor: 4.965

8.  Immunocytochemical analysis of blood lymphocytes in uveitis.

Authors:  A D Dick; Y F Cheng; A T Purdie; J Liversidge; J V Forrester
Journal:  Eye (Lond)       Date:  1992       Impact factor: 3.775

9.  Immunohistochemistry and electron microscopy of choroidal infiltrates and Dalen-Fuchs nodules in sympathetic ophthalmia.

Authors:  C C Chan; D Benezra; M M Rodrigues; A G Palestine; S M Hsu; A L Murphree; R B Nussenblatt
Journal:  Ophthalmology       Date:  1985-04       Impact factor: 12.079

10.  Cellular immune responsiveness of uveitis patients to retinal S-antigen.

Authors:  R B Nussenblatt; I Gery; E J Ballintine; W B Wacker
Journal:  Am J Ophthalmol       Date:  1980-02       Impact factor: 5.258

View more
  2 in total

Review 1.  Management of uveitis in pediatric patients: special considerations.

Authors:  Justine R Smith
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

2.  Use of the Fluocinolone Acetonide Intravitreal Implant for the Treatment of Noninfectious Posterior Uveitis: 3-Year Results of a Randomized Clinical Trial in a Predominantly Asian Population.

Authors:  Virender S Sangwan; P Andrew Pearson; Hemanth Paul; Timothy L Comstock
Journal:  Ophthalmol Ther       Date:  2014-12-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.